However, the occurrence of breast cancer rarely depends solely on the PI3K signaling pathway, and PI3K inhibitors are often used in combination with other treatments to increase the sensitivity of breast cancer patients to drugs and reduce drug resistance. Here, PIK3CA is linked to breast cancer.